Commitment
to Research
|
 |
Current Radiation Therapy
Oncology Group’s (RTOG) Brain Tumor Research Trials
RTOG R0212
A Phase II/III Randomized Trial Of Two
Doses (Phase III – Standard Vs. High) And Two High Dose Schedules
(Phase II – Once Vs. Twice Daily) For Delivering Prophylactic
Cranial Irradiation For Patients With Limited Disease Small Cell
Lung Cancer.
RTOG R0214
A Phase III Comparison Of Prophylactic
Cranial Irradiation Versus Observation In Patients With Locally
Advanced Non-Small Cell Lung.
RTOG R0525
Phase III Trial Comparing Conventional
Adjuvant Temozolomide With Dose-Intensive Temozolomide In Patients
With Newly Diagnosed Glioblastoma.
RTOG R9813
A Phase III
Randomized Study of Radiation Therapy And Temozolomide
Versus Radiation Therapy and
Nitrosourea For Anaplastic Astrocytoma And Mixed Anaplastic
Oligoastrocytoma (Astrocytoma Dominant).
|
